Full Article

E Pujade-Lauraine

Hong Kong J Radiol 2013;16(Suppl):S4-8

Ovarian cancer is the leading cause of gynaecological cancer death in Hong Kong. It is often diagnosed late due to the absence of a means for routine screening. Up to 75% of patients

Full Article

EP Hui

Hong Kong J Radiol 2013;16(Suppl):S17-22

The last 30 years have witnessed numerous advances in the management of metastatic colorectal cancer leading to an expansion in treatment options and improvement in treatment outcomes. The management of

Full Article

ESK Ma

Hong Kong J Radiol 2013;16(Suppl):S29-33

BRAF is a protein kinase in the mitogen-activated protein kinase pathway that regulates cell proliferation, differentiation, and survival. Mutation in the BRAF gene can lead to aberrant activation of the

Full Article

EKC Lee

Hong Kong J Radiol 2013;16(Suppl):S39-43

Patients with localised prostate cancer can be cured with radical prostatectomy alone. Nevertheless, many of them may develop local failure due to positive surgical margins or residual disease from extraprostatic

Full Article

BMY Cheung

Hong Kong J Radiol 2013;16(Suppl):S50-4

Biologics are complex proteins derived from living organisms that have been used successfully in treating many different diseases. As some biologics approach patent expiration, the development of drugs that are

Full Article

JCM Ho

Hong Kong J Radiol 2013;16(Suppl):S55-9

In advanced pulmonary carcinoma, determination of epidermal growth factor receptor (EGFR) mutation status, histology, and anaplastic lymphoma kinase (ALK) mutation status can be highly instructive for guiding the course of

Full Article

SKH Yip

Hong Kong J Radiol 2013;16(Suppl):S66-8

Prostate cancer is the third most common cancer affecting men in Hong Kong, and the fifth leading cause of cancer death in Hong Kong males. The diagnosis of prostate cancer